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ABSTRACT 
 
 
The Timing of Phage DNA Replication Influences Cellular Decision-making 
 
 
James Corban 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
 
Research Advisor: Dr. Lanying Zeng 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
 
In this study, we use the bacteriophage lambda and E. coli model system to examine the 
effects of lambda DNA replication on the lysis-lysogeny decision. In the lytic pathway, lambda’s 
structural and lysis genes are rapidly transcribed and translated, culminating with the burst of the 
host cell and release of ~one hundred progeny virions which conduct further infection cycles. 
The temperate lysogenic pathway consists of the integration of the lambda genome into the host 
chromosome and the maintenance of stable, replicating lysogenic cells via the repression of 
lambda lysis and replication genes. We employ nalidixic acid (NA), a quinolone antibiotic, as an 
inhibitory agent to lambda DNA replication. NA inhibits DNA gyrase, leading to the buildup of 
positive supercoiling stress ahead of replication forks and a stall in DNA replication. Both E. coli 
and phage lambda rely on DNA gyrase for maintaining their respective DNA molecules in 
proper supercoiled states to facilitate DNA replication. In this work, we determine that a delay to 
the start of lambda DNA replication significantly affects decision-making in the lysis-lysogeny 
system and we discuss the mechanisms which could lead to the altered outcomes. We also 
examine an alternate method of altering lambda DNA replication by controlling the production 
of lambda-specific DNA replication proteins, a protein critical specifically for initiating the 
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replication of lambda DNA molecules. By infecting cells which may be induced to express O or 
P with lambda mutants which are deficient for that protein, we could potentially observe 
variances in the lysis-lysogeny decision at distinct DNA replication rates. 
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CHAPTER I 
INTRODUCTION 
 
 
Ubiquitous in biological systems, cellular decision-making describes the process by 
which distinct phenotypic outcomes result from the varied expression of genes along regulatory 
cascades (1). Decision-making at the single-cell level can be magnified within cellular 
populations, which in many cases (such as sporulation, apoptosis, or tumorigenesis) translate to 
significant impacts on the health and behavior of multicellular organisms (2, 3). Numerous intra- 
and extracellular factors can contribute to gene expression involved in cellular decision-making, 
including environmental conditions (temperature, pressure, etc.), nutrient availability, population 
density, or the abundance of transcriptional or translational regulators (1, 4). DNA copy number 
fluctuation via DNA replication is a factor in gene expression experienced to varying degrees by 
nearly every biological system (1). Increased gene dosage could amplify the expression of a 
given gene while decreased gene dosage could dampen expression, with either eventuality 
subjecting organisms to altered phenotypes (1, 5). Diverse regulatory responses can tune the 
sensitivity or robustness of gene networks to DNA copy number changes to achieve the optimal 
phenotypic outcome for the organism (or its population) (6). Investigating the effects of altered 
DNA replication patterns (and the resultant DNA copy number fluctuation) on cellular decision-
making outcomes may provide valuable insight into the role of gene dosage on regulatory 
network expression.  
In this work, we study the bacteriophage lambda and E. coli infection cycle to examine 
the effects of altered lambda DNA replication on the lysis-lysogeny decision. The lambda lysis-
lysogeny decision, often referred to as the “genetic switch”, stands as one of the most well-
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defined models of cellular decision-making (7). In the lytic pathway, lambda’s structural and 
lysis genes are rapidly transcribed and translated, culminating with the burst of the host cell and 
release of several hundred progeny virions which conduct further infection cycles (7). The 
comparatively temperate lysogenic pathway consists of the integration of the lambda genome 
into the host chromosome and the maintenance of stable, replicating lysogenic cells via the 
repression of lambda lysis and replication genes (7). Past studies have demonstrated that phage 
lambda DNA replication is integral to the lysis-lysogeny decision (1, 8).  
We employed two separate strategies to alter lambda DNA replication patterns during the 
infection process. Nalidixic acid (NA), a quinolone antibiotic, was used as an inhibitory agent to 
lambda DNA replication (9). NA targets DNA gyrase and inhibits the enzyme’s nicking-closing 
activity, leading to the buildup of positive supercoiling stress ahead of replication forks and a 
stall in DNA replication (9). Both E. coli and phage lambda rely on DNA gyrase for maintaining 
their respective DNA molecules in proper supercoiled states to facilitate DNA replication. We 
applied concentrations of NA with negligible effects on E. coli viability to examine the impact of 
NA treatment on lambda DNA replication and the lysis-lysogeny decision. The second strategy 
used to alter lambda DNA replication centered on controlling the production of lambda 
replication proteins, O and P.  The lambda O protein functions similarly to DnaA in E. coli: a 
sufficient accumulation of O triggers the opening of lambda’s replication fork and allows for 
replication to begin (10). P interacts with host DnaB and shuttles the protein to the lambda 
replication fork to facilitate opening of the double-stranded lambda genome (11). Cells 
containing plasmids inducible for P or O expression were infected with P or O (respectively) 
deficient lambda mutants. 
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Our study indicates that a delay to the start of lambda DNA replication significantly 
affects decision-making in the lysis-lysogeny system and we discuss the mechanisms which 
could lead to the altered phenotypic outcomes. Future studies will provide a greater level of 
clarity on the impact of controlled P or O expression on lambda decision-making.  
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CHAPTER II 
METHODS 
 
 
Strains, Plasmids, and Phages 
 The host E. coli strain for the normal single-cell infection assays and qPCR analysis was 
MG1655. The host used for single-cell phage DNA copy number tracking assays was MG1655 
pACYC177-PFtsKi-tetR-mNeonGreen.  
 The plasmids pBAD33 (12) and pZS*24 (13) each expressing P were transformed into a 
MG1655 lacY-lacIQ strain (MG1655 lacY-lacIQ-pBAD33-P and MG1655 lacY-lacIQ-pZS*24-
P).  Similarly, pBAD33 and pZS*24 each expressing O were transformed into MG1655 lacY-
lacIQ (MG1655 lacY-lacIQ-pBAD33-O and MG1655 lacY-lacIQ-pZS*24-O).  
The reporter phage for normal single-cell infection assays was λD-mTurquoise2 cI857-
mKO2 bor::CmR (8) (Fig. 1). Phage λD-mTurquoise2 cI857-mKO2 bor::48xtetO CmR was used 
for single-cell DNA copy number tracking movies. The phage used in qPCR analysis was λcI857 
bor::KanR. λP- phage (λcI857 Pam80 bor::KanR) was used for infections of MG1655 lacY-
lacIQ-pBAD33-P and MG1655 lacY-lacIQ-pZS*24-P strains. All phages were purified as 
previously described (8). 
 
 
 
 
 
 
Figure 1:  A cell infected with λD-mTurquoise2 cI857-mKO2 bor::CmR 
expressing both lytic and lysogenic activity (referred to in this study as 
“mixed-fate” cells) (8). Lytic expression: gpD-mTurq2 (blue). Lysogenic 
expression: cI-mKO2 (yellow). 
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DNA Quantification at Bulk-Level via qPCR 
 One mL overnight culture of E. coli MG1655, grown at 37°C in M9MM (M9 minimal 
media + 0.4% maltose + 10 mM MgSO4) with 265 rpm shaking, was diluted 1:100 into 20 mL 
M9MM. The culture was grown at 37°C with 265 rpm shaking to OD600 ~0.4. The cells were 
collected by centrifugation (2000g, 4°C, 15 min), the supernatant was discarded, and the pellet 
was resuspended with 1:10 volume of fresh ice-cold M9MM. An appropriate amount of λLZ613 
was added to the sample to reach a target API of 2 (average phage infection, e.g. the average 
infected cell is infected by two phages), with pipetting to mix.  The cell+phage mixture was 
incubated on ice for 30 minutes to allow for phage adsorption. While the sample was on ice, 1.8 
mL of M9GM (M9 + 0.2% glucose + 10 mM MgSO4) was added to six new falcon tubes (for 20, 
40, 60, 80, 100, and 120-minute samples). The six M9GM tubes were pre-warmed in a 30°C 
water bath. Seven 15 mL centrifuge tubes were filled with two mL of methanol and stored at -
20°C. An ethanol-dry ice slurry was prepared with sufficient depth to submerge a 15 mL 
centrifuge tube to the four mL mark. The cell+phage mixture was transferred to a 35°C water 
bath and incubated for five minutes. The sample was immediately diluted by adding 200 μL to 
each of the six M9GM tubes prewarmed at 30°C. For the 0-minute sample, 200 μL was added 
directly to two mL chilled methanol and immediately placed in the ethanol-dry ice slurry to 
freeze. The six M9GM sample tubes were incubated at 30°C with 225 rpm shaking, with one 
sample being transferred to the ethanol-dry ice slurry every 20 minutes up to a final time point of 
120 minutes. After being left in the ethanol-dry ice slurry for two minutes, each sample was 
centrifuged (4000g, 4°C, 10 min) and the methanol was discarded. The remaining pellet for each 
sample was stored at -20°C.  
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 DNA extraction for each sample was performed with the UltraClean Microbial DNA 
Isolation Kit (MO BIO Laboratories, #12224-50) following standard protocols. SYBR Green 
PCR master mix was used for DNA detection. For each sample, primers targeting the phage 
genome were used to quantify phage DNA, while E. coli DNA was quantified using primers 
which targeted the dxs gene (Table 1) (1).  
 
 
 
Single-cell Infection Assay 
One mL of overnight culture of MG1655 (grown in M9M at 37°C with 265 rpm shaking) 
was diluted 1:100 into M9M. The culture was grown at 37°C with 265 rpm to OD600 ~0.4. 1 mL 
of the grown culture was collected in a microcentrifuge tube and centrifuged (4000g, 4 min), the 
supernatant was discarded, and the pellet was resuspended in 1:10 volume of fresh ice-cold 
M9M (for experiments with NA, the pellet was resuspended in 1:10 volume of ice-cold M9M 
with 2x final NA concentration). 20 μL of the cells was transferred to a separate microcentrifuge 
tube and mixed (by gentle pipetting) with 20 μL of phage at an appropriate titer. The cell+phage 
mixture was incubated on ice for 30 minutes. A separate tube was prepared with 40 μL M9M 
(for experiments with NA, used 40 μL M9M with 1x final NA concentration) and left at room 
temperature. The cell+phage mixture was incubated in a 35°C water bath for five minutes. While 
waiting, a small 1.5% agarose M9M pad was placed onto an 18x18mm Fisher Scientific 
coverslip. 10 μL of the cell+phage mixture was transferred (with a pipette tip cut to provide a 
larger opening) to the tube containing 40 μL M9M and lightly tapped to mix. Next, 1 μL of the 
E. coli dxs forward primer E. coli dxs reverse primer Lambda E forward primer Lambda E reverse primer 
5'-CGAGAAACTGGCGATCCTTA 5'- CTTCATCAAGCGGTTTCACA 5'- CTGGGTGAACAACTGAACCG 5'- ATCCGTGTCATCAAGCTCCT 
Table 1. Primers used for qPCR experiments which target E. coli or phage lambda DNA. 
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sample was pipetted (with a cut pipette tip) onto the M9M pad. After the sample was dried (~one 
minute), a 24x50mm Fisher Scientific coverslip was placed onto the M9M pad, and the sample 
was imaged by microscope following previously established protocols (8).  
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CHAPTER III 
RESULTS 
 
 
Effects of Nalidixic Acid Treatment on E. coli MG1655 Viability  
 Preliminary experiments were performed to determine working NA concentrations at 
which delayed lambda DNA replication was observed with negligible impacts on E. coli 
MG1655 viability. Single-cell analysis of infected cells (from fluorescence microscopy imaging) 
grown in the presence of 10 μg/mL NA demonstrated no apparent increase in death rates 
(excluding deaths due to lytic events). Cells treated with 20 μg/mL NA demonstrated only mildly 
increased death rates (~5-10% higher) at MOI 0-2. To verify that NA treatment at 10 and 20 
μg/mL did not interfere with ejection of phage DNA into the cell or block lambda lysis-lysogeny 
gene expression, the failed infection rates (cells with visibly adsorbed phages exhibiting no lytic-
lysogenic activity) of NA treatment groups were measured. No significant variations in failed 
infection rates were detected at any MOI for the NA treatment groups as compared to infected 
cells grown in the absence of NA.  
Nalidixic Acid Treatment Corresponds with Delayed Lambda DNA Replication 
We quantified phage DNA levels in populations of infected cells with and without NA 
treatment over time (Fig.2). A distinct delay in phage DNA replication was observed, 
distinguishable at the 20-minute time point in Fig.2a. This delay appeared complete: no increase 
in phage DNA fold change was detected. By taking the log of the fold change values (excluding 
the 0-minute point for the NA treatment groups) and comparing the slope values for each dataset, 
the rate of phage DNA replication in the NA treatment groups following the delay was found to 
be essentially unchanged as compared to the control group. 
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 Figure 2: Data for each treatment group represents average of three separate qPCR trials. (a) Phage lambda DNA levels in 
infected E. coli cells over time as detected via qPCR. Fold change calculated as ratio of phage DNA over E. coli DNA in 
each treatment group and normalized to the ratio measured at 0 min. (b) Log of DNA levels given in Fig. 2a. Rates of phage 
DNA replication for each treatment group represented by values of linear trendline slopes (indicated by arrows). 
b 
a 
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Next, we sought to visualize the observed delay in phage DNA replication at the single-
cell level via the application of a tetracycline expression system (10). An MG1655 strain was 
transformed with a multi-copy number plasmid constitutively expressing TetR protein fused with 
the fluorescent protein mNeongreen. A phage was constructed with 48 tetO regions which are 
selectively recognized by TetR. Upon injection of phage DNA into the host cell, TetR-
mNeongreen binds to the tetO regions. By visualizing the mNeongreen fluorescence signal, 
clusters of phage DNA can be tracked via time-lapse microscope imaging. Once background 
mNeongreen fluorescence intensity is subtracted, the fluorescence intensity produced by a single 
phage DNA molecule can be used as a baseline by which to quantify phage DNA copy number 
over time in infected cells (e.g. 20x the signal associated with a single phage DNA molecule 
would represent 20 phage DNA molecules). Representative time-lapse images of a tetO-TetR 
infection are shown in Fig.3. The MATLAB script with which we are analyzing teto-TetR-
mNeongreen image data remains under development, although preliminary results appear to 
corroborate the delayed start to phage DNA replication observed via bulk-level DNA 
quantification. 
 
  
 
 
 
 
 
 
 Figure 3: Images taken from a time-lapse infection movie using the tetO-TetR-mNeongreen 
system (0 minute image is taken approximately 15 minutes post phage injection into cell). The 
green fluorescence bordered by yellow indicates phage DNA labeled with TetR-mNeongreen. 
         0 min    20 min                    45 min 
14 
Delayed Lambda DNA Replication Impacts Lysis-Lysogeny Decision 
Phage lambda decision-making was assayed at the single-cell level via fluorescence 
imaging with two fluorescent proteins used as our reporters: mTurquoise2 and mKO2 (Fig.5) (8). 
The mTurquoise2 gene was translationally fused to the λD gene, which encodes the capsid 
decoration protein gpD (present in several hundred copies on each capsid) (8). Therefore, 
mTurquoise2 signal allowed for the detection of lytic activity (via the labeling of assembling 
phages in lytic cells) and the quantification of infecting phages for each cell (8). The mKO2 gene 
was transcriptionally fused downstream of cI to function as a lysogeny reporter, with mKO2 
expressed as a separate protein so as to avoid interfering with CI activity (8). The cI operon is 
expressed during the establishment and maintenance of lysogeny (7). All infections for 
microscopy imaging were performed in M9M (M9 minimal media + 0.4% maltose) media to 
optimize the measurement of fluorescent signals.  
The percentage of infected cells expressing pure lytic activity (i.e. no lysogenic signal) 
was significantly reduced in the NA treatment groups, especially at low MOI (Fig.4a). At MOIs 
of 1 and 2, pure lysis percentage was reduced by 30-50% with NA treatment.  As expected, 
lysogeny rates increased with MOI for infected cells grown with and without NA (Fig.4b) (8). 
Relative to the control, a higher percentage of lysogeny was observed for NA at low MOI (1-2) 
and a lower percentage was observed at high MOI (3-4). Most notably, a sharp increase in the 
percentage of mixed fate cells (expressing both lytic and lysogenic activity) was observed with 
NA treatment (Fig.4c). Between 35-50% of infected cells in the NA treatment groups were 
mixed at MOI 1-4, as compared to ≤10% at MOI 1-4 in the control. NA treatment also 
corresponded with significantly delayed lysis times. As compared to the control cells, the 
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average lysis time was delayed by 85 minutes with 10 μg/mL NA and 110 minutes with 20 
μg/mL NA (Fig.4d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4: Single-cell infection data from fluorescence microscopy imaging. (a) Percentage of 
infected cells expressing pure lysogenic activity. (b) Percentage of infected cells expressing pure 
lytic activity. (c) Percentage of infected cells expressing both lytic and lysogenic activity (“mixed” 
fate cells). (d) Fraction of total lytic cells (pure lytic + mixed) which lysed at given time points.  
b 
c
a 
d
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Impact of Controlled P and O Protein Expression on Lambda Lysis-Lysogeny Decision 
E. coli strains were transformed with plasmids which inducibly express O or P. These 
strains will be infected by lambda phages deficient for O or P expression. The bulk-level DNA 
quantification of these infected cells will be quantified via qPCR (with results depicted in the 
same format as displayed in Fig.2). These results will determine if: (a) the rate of lambda DNA 
replication is lowered in infections with O/P deficient phages; (b) O/P deficient lambda DNA 
replication can be fully recovered with sufficient O/P expression from their host strains; (c) if 
overexpression of O/P can increase lambda DNA replication relative to that of wild type 
infections. If the bulk-level DNA quantification results indicate that the lambda DNA replication 
rate was lowered relative to the control group (cells infected with wild-type lambda), then single-
cell fluorescence infection assays will be performed (as previously described) to quantify phage 
DNA at the single cell level over time (via the tetO-TetR-mNeongreen method, Fig.5) and to 
determine whether the altered DNA replication rates impact the frequencies of lysis-lysogeny 
decision outcomes.  Due to the events surrounding the COVID-19 virus in the spring of 2020, 
these experiments and their corresponding results were unavailable at the time of publication for 
this URS thesis.  
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Several cycles of 
lambda DNA replication: 
Figure 5: Graphic representation of tetO-Tetr-mNeongreen array which will be used to quantify phage DNA 
levels over time at the single-cell level in cells expressing O infected with O-deficient phages. The increase 
in phage DNA can be measured in relation to elevations in fluorescence intensity over time. Infection of 
cells inducibly expressing O (a lambda specific DNA replication protein) with lambda O- phages will allow 
for controlled rates of replication. An identical approach to this figure will be used for the inducible 
expression of P. 
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CHAPTER IV 
CONCLUSION 
 
Insights gained from the study of cellular decision-making mechanisms within model 
biological systems such as phage lambda are necessary for understanding critical processes 
including organismal development and disease progression (1). In this work, nalidixic acid was 
identified as a lambda DNA replication delay agent and the corresponding effects of this delay 
on the lysis-lysogeny decision were examined. 
Following the observed delay to the start of phage DNA replication, the rate of phage 
DNA replication in the NA treatment groups closely reflected that of the control group. While 
the precise explanation behind this outcome has not yet been determined, certain factors have 
been hypothesized to be involved. Upon injection into the host cell, lambda DNA first undergoes 
several cycles of theta replication. The theta mode of replication consists of bidirectional 
replication initiated from the oriλ site and produces daughter circles of the phage genome (14). 
Late-stage DNA replication (~15 minutes post-infection in ideal lysis conditions) involves the 
switch from theta to sigma, or rolling-circle, replication (14). The sigma mode consists of 
unidirectional replication and the creation of long, linear dsDNA concatemers of the phage 
genome (14). The precise mechanism of the replication mode switch remains unconfirmed. 
Previous studies have demonstrated that continued transcription at oriλ corresponds with 
bidirectional replication, while stalls in transcription lead to a subsequent switch to unidirectional 
sigma replication (14, 15). We hypothesize that the observed delay in phage DNA replication 
may be associated with the theta/sigma replication switch. As stated previously, NA inhibits 
DNA replication by creating a buildup of positive supercoiling stress ahead of replication forks. 
The stress buildup may inhibit transcription at oriλ, leading to a switch to sigma replication. The 
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inhibitory effect of the increased positive supercoiling stress on the rate of phage DNA 
replication may be lessened when the DNA is being replicated unidirectionally in a linear 
dsDNA format (sigma), as opposed to bidirectionally in a circular dsDNA format (theta). 
Therefore, a delay in replication would be observed during early replication (while in theta 
mode) while replication may return to a normal rate in late replication (sigma mode).    
The most dramatic difference observed in the lysis-lysogeny decision due to a delay in 
phage DNA replication was a substantial increase in mixed fate cells. This outcome could be due 
to a buildup of the lambda transcriptional repressors Cro and CI (or specifically, an accumulation 
of CII which transcriptionally activates cI) during delayed replication (7). Cro binding is 
associated with lytic activity, while CI binding is associated with lysogenic activity. These two 
proteins compete with each other for the same binding sites, and whichever protein “wins” the 
contest switches the lysis-lysogeny circuit to commit to the victor’s pathway while repressing the 
activity of the loser (e.g., if Cro “wins”, lysis and replication genes are rapidly transcribed while 
genes associated with lysogeny are repressed) (15).  With delayed replication, CI and Cro would 
continue to accumulate while the number of phage genomes remained the same. Upon the switch 
to increased phage DNA replication, a surge in lambda DNA could generate a rapid binding 
competition between latent pools of Cro and CI. This could confuse the normal lysis-lysogeny 
decision and contribute to the observed increase in combined lytic and lysogenic activity in 
infected cells. A prominent factor in the delayed lysis times observed for the NA treatment 
groups was most likely the greatly increased proportion of mixed cells in those groups. As 
demonstrated in previous studies, cells expressing both lytic and lysogenic activity experience 
“confusion” and result in delayed lysis times (8). 
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In future studies, we intend to refine the tetO-TetR-mNeongreen method used for the 
tracking and quantification of phage DNA copy number within infected cells. A significant 
problem we encountered while quantifying phage DNA copy number via time-lapse microscopy 
was that the actual mNeongreen signal may be partially obscured or difficult to visualize 
depending on the 3-D organization of the DNA molecules at any given time point. As a result, 
measured fluorescence signals could be higher or lower than their true value. To remedy this, 
additional time-lapse movies were performed with five z-stack (+/- 0.6 μm with spacing of 0.3 
μm) images at each stage. The MATLAB script we will use to analyze data from these z-stack 
movies is currently being optimized. Ideally, analysis of the tetO-tetR-mNeongreen movies will 
both verify our observed delay in phage DNA replication and allow us to visualize any resultant 
alteration to phage DNA localization within the cell. Additionally, bulk-level and single-cell 
level DNA quantification will be performed on O/P expressing E. coli strains infected with O/P 
deficient lambda phages to verify whether controlled O/P expression can lower or (with 
sufficient expression) raise the rate of lambda DNA replication. Single-cell fluorescence 
infection assays with O/P deficient phages will be performed to demonstrate the impact of 
altered DNA replication on lysis-lysogeny decision outcomes. 
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